Sponsored By

What Trump's Dr. Oz Nomination Means for Medtech

Scott Whitaker, president and CEO at AdvaMed, reacted positively to the news that the heart surgeon and former television talk show host will be nominated to run CMS.

Amanda Pedersen

November 20, 2024

3 Min Read
Close up photo of Dr. Oz attending The Swift Hour during the 2024 Concordia Annual Summit at Sheraton New York Times Square in September 2024
Dr. Oz attends The Swift Hour during the 2024 Concordia Annual Summit at Sheraton New York Times Square on September 24 in New York, NY. Image credit: Leigh Vogel / Contributor / Getty Images

President-elect Donald Trump's pick for Centers for Medicare and Medicaid Services administrator, heart surgeon turned television personality and politician Mehmet Oz, MD, better known as Dr. Oz, has drawn mixed reactions.

"America is facing a healthcare crisis, and there may be no physician more qualified and capable than Dr. Oz to Make America Healthy Again," Trump wrote in a statement posted Tuesday on Truth Social. "...Dr. Oz will work closely with Robert F. Kennedy Jr. to take on the illness industrial complex and all the horrible chronic diseases left in its wake."

The announcement follows last week's news that Trump plans to nominate Robert F. Kennedy Jr. (RFK Jr.) to oversee the Department of Health and Human Services. Kennedy recently raised eyebrows for his plans to clear out entire departments at FDA due to so-called corruption at the agency.

"Our broken healthcare system harms everyday Americans and crushes our country's budget. Dr. Oz will be a leader in incentivizing disease prevention so we get the best results in the world for every dollar we spend on healthcare in our great country. He will also cut waste and fraud within our country's most expensive government agency, which is a third of our nation's healthcare spend and a quarter of our entire national budget."

Related:What's at Stake for Medtech as Trump Wins the Presidency?

View post on X

Oz graduated from Harvard University, and he obtained MD and MBA degrees from the University of Pennsylvania School of Medicine and Penn's Wharton School. He completed his surgical training in cardiothoracic surgery at New York Presbyterian Hospital (Columbia Campus). He became a professor of surgery at Columbia University and is a co-inventor of Abbott's MitraClip. He also won nine Daytime Emmy Awards hosting "The Dr. Oz Show."

Scott Whitaker, president and CEO of AdvaMed, praised the nomination.

“Dr. Oz has firsthand experience with medical technology and as a result understands the incredible impact these technologies can have in the lives of patients in need. And as a practitioner, he has also seen firsthand the negative impact a lack of access to these technologies can have on these same patients," Whitaker said in a statement shared with MD+DI. "When the best medical technology is in the hands of skilled surgeons and doctors, we can help heal the sickest patients, prevent disease progression, and restore the health of the American people. We look forward to working with Dr. Oz to strengthen access to and coverage of the transformative medical technologies, treatments, and diagnostic tests that help Americans in every corner of the country to live longer, healthier lives.”

While there are plenty who support the choice, Oz is no stranger to controversy.

During the early days of the COVID-19 pandemic, Oz promoted hydroxychloroquine, an anti-malarial drug, as a COVID-19 treatment. FDA later revoked emergency authorization for hydroxychloroquine and chloroquine to treat COVID-19 after evidence showed the recommended dose was unlikely to be effective against the virus. Oz is also known for his claims about certain "miracle" products to help people lose weight.

View post on X

Despite past controversies, however, Trump expressed confidence in his choice.

"I have known Dr. Oz for many years, and I am confident he will fight to ensure everyone in America receives the best possible healthcare so our country can be great and healthy again," Trump wrote in his Truth Social post.

About the Author

Amanda Pedersen

Amanda Pedersen is a veteran journalist and award-winning columnist with a passion for helping medical device professionals connect the dots between the medtech news of the day and the bigger picture. She has been covering the medtech industry since 2006.

Sign up for PlasticsToday newsletter

You May Also Like